Drugmakers Pfizer Inc, BioNTech and Moderna Inc are expected to reap billions of dollars from COVID-19 booster shots in a market that could rival the ...
Pharmaceutical company BioNTech said Monday that it wants to use the mRNA technology behind its coronavirus vaccine to target malaria.The ...
BioNTech on Monday said there was “no evidence” its jabs need to be adapted against coronavirus variants yet.For more coronavirus news, visit our ...
COVID-19 jab maker BioNTech said Monday it would build a factory in Singapore that could produce hundreds of millions of doses of vaccines based on ...
Pfizer Inc on Tuesday forecast $26 billion in sales of the COVID-19 vaccine this year, an increase of more than 70 percent from its last projection ...
BioNTech expects results by September from trials testing the COVID-19 vaccine that it and Pfizer have developed in babies as young as six months old, ...
Europe can achieve herd immunity against the coronavirus within three to four months, the head of German pharmaceutical company BioNTech, which ...
BioNTech said on Tuesday that it and partner Pfizer would increase manufacturing capacity of their COVID-19 vaccine to 2.5 billion doses by the end of ...
Swiss pharmaceuticals giant Novartis said Friday it had signed an initial agreement to help produce the Pfizer-BioNTech vaccine against COVID-19, as ...
The COVID-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus discovered in Britain which ...
Some European countries are drawing fewer than the approved six doses from Pfizer and BioNTech’s COVID-19 vaccine vials, meaning shotsare likely going ...
Six European Union governments asked the executive EU Commission in a letter on Friday to pressure Pfizer-BioNTech, “to ensure stability and ...
European countries rolling out the Pfizer-BioNTech COVID-19 vaccine should be flexible on the time between the first and second doses, the World ...
BioNTech and partner Pfizer warned on Monday that they had no evidence that their jointly developed vaccine will continue to protect against COVID-19 ...
Scientists are not fully confident that COVID-19 vaccines will work on a new variant of the coronavirus found in South Africa, ITV’s political editor ...
BioNTech is working flat out with partner Pfizer to boost production of their COVID-19 vaccine, its founders said, warning there would be gaps in ...
Drug makers including BioNTech and Moderna are scrambling to test their COVID-19 vaccines against the new fast-spreading variant of the virus that is ...
Swiss drugs regulator Swissmedic has authorised the COVID-19 vaccine from Pfizer and partner BioNTech, the agency said on Saturday.“According to the ...
The US Food and Drug Administration (FDA) said Thursday it was working with Pfizer to revise a fact sheet for recipients of the Pfizer-BioNTech ...
US Food and Drug Administration staff members did not raise new concerns over data on Moderna Inc’s coronavirus vaccine in documents made public on ...
Germany’s health minister demanded that the European Union’s regulatory agency work faster to approve a coronavirus vaccine and bring an end to the ...
The head of the European Union drug regulator said on Thursday the agency’s work assessing COVID-19 vaccines had not been disrupted by a cyberattack ...
US drugmaker Pfizer and its German partner BioNTech said on Wednesday that documents related to their development of a COVID-19 vaccine had been ...
We use cookies to improve your experience on our site and to show you personalized advertising. To continue browsing, please click ‘OK, I Accept’.
For more information, please read our Privacy Policy
